University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...

We wish to determine whether adding ketamine to existing treatment would terminate status epilepticus in more patients than the current treatment,” said neurologist Jaideep Kapur, MD, PhD, co-director ...

Epilepsy is a chronic disease of the human brain characterised by recurrent seizures or “fits”. These are short periods of ...